| Incidence and outcomes of bloodstream infections among hematopoietic cell transplant recipients from species commonly reported to be in over‐the‐counter probiotic formulations SA Cohen, MC Woodfield, N Boyle, Z Stednick, M Boeckh, SA Pergam Transplant Infectious Disease 18 (5), 699-705, 2016 | 62 | 2016 |
| In vitro inactivation of latent HSV by targeted mutagenesis using an HSV-specific homing endonuclease M Aubert, NM Boyle, D Stone, L Stensland, ML Huang, AS Magaret, ... Molecular Therapy-Nucleic Acids 3, 2014 | 58 | 2014 |
| Evaluating Risk Factors for Clostridium difficile Infection in Adult and Pediatric Hematopoietic Cell Transplant Recipients N Boyle IDWeek 2014, 2014 | 36 | 2014 |
| Low-dose 0.01% atropine eye drops vs placebo for myopia control: a randomized clinical trial MX Repka, KK Weise, DL Chandler, R Wu, BM Melia, RE Manny, ... JAMA ophthalmology 141 (8), 756-765, 2023 | 24 | 2023 |
| Visual acuity and ophthalmic outcomes 5 years after cataract surgery among children younger than 13 years MX Repka, TW Dean, RT Kraker, Z Li, KG Yen, AG de Alba Campomanes, ... JAMA ophthalmology 140 (3), 269-276, 2022 | 15 | 2022 |
| Low-and very low-dose bevacizumab for retinopathy of prematurity: reactivations, additional treatments, and 12-month outcomes SF Freedman, A Hercinovic, DK Wallace, RT Kraker, Z Li, AR Bhatt, ... Ophthalmology 129 (10), 1120-1128, 2022 | 13 | 2022 |
| Bacterial foodborne infections after hematopoietic cell transplantation NM Boyle, S Podczervinski, K Jordan, Z Stednick, S Butler-Wu, ... Biology of Blood and Marrow Transplantation 20 (11), 1856-1861, 2014 | 12 | 2014 |
| The pediatric optic neuritis prospective outcomes study: Two-year results SL Pineles, RJ Henderson, MX Repka, G Heidary, GT Liu, AT Waldman, ... Ophthalmology 129 (8), 856-864, 2022 | 9 | 2022 |
| Choice of dose level for a randomized clinical trial of low-dose bevacizumab vs laser for type 1 retinopathy of prematurity RT Kraker, DK Wallace, RW Beck, CT Saunders, E Lorenzi, BM Melia, Z Li, ... JAMA ophthalmology 139 (10), 1143-1144, 2021 | 8 | 2021 |
| Incidence of glaucoma-related adverse events in the first 5 years after pediatric lensectomy ED Bothun, MX Repka, RT Kraker, R Wu, DA Leske, SR Hatt, Z Li, ... JAMA ophthalmology 141 (4), 324-331, 2023 | 7 | 2023 |
| Complications occurring through 5 years following primary intraocular lens implantation for pediatric cataract KG Yen, MX Repka, DR Sutherland, KM Haider, SR Hatt, RT Kraker, ... JAMA ophthalmology 141 (8), 705-714, 2023 | 4 | 2023 |
| Visual outcomes and complications after lensectomy for traumatic cataract in children SF Freedman, LB Enyedi, S Prakalapakorn, SK Jones, D Hug, ED Stahl, ... JAMA ophthalmology 139 (6), 647-653, 2021 | 3 | 2021 |
| Eight-Year Outcomes of Bilateral Lateral Rectus Recessions versus Unilateral Recession-Resection in Childhood Basic-Type Intermittent Exotropia SP Donahue, DL Chandler, R Wu, JD Marsh, C Law, RG Areaux Jr, ... Ophthalmology 131 (1), 98-106, 2024 | 1 | 2024 |
| Doses of medial rectus muscle recessions for divergence insufficiency-type esotropia AM Miller, JM Holmes, R Wu, RT Kraker, ER Crouch, KA Lee, ... Journal of AAPOS: the official publication of the American Association for …, 2024 | | 2024 |
| Refractive Error Change and Overminus Lens Therapy for Childhood Intermittent Exotropia ML Alexander, M Allen, S Alluri, DM Amster, HA Anderson, A Argoubi, ... JAMA Ophthalmology, 2024 | | 2024 |
| Clostridium difficile Infection Incidence and Risk Factors within Pediatric and Adult Hospitalization Sites after Allogeneic Hematopoietic Cell Transplantation NM Boyle | | 2014 |
| Incidence and Outcomes of Bacteremia with Common Over-the-Counter Probiotic Organisms Among Hematopoietic Cell Transplant Recipients M Woodfield, N Boyle, Z Stednick, MJ Boeckh, SA Pergam Biology of Blood and Marrow Transplantation 20 (2), S205-S206, 2014 | | 2014 |
| Incidence of Post-Transplant Bacterial Foodborne Pathogens in Hematopoietic Stem Cell Transplant Patients N Boyle, S Podczervinski, K Jordan, Z Stednick, S Butler-Wu, K McMillen, ... Biology of Blood and Marrow Transplantation 19 (2), S259, 2013 | | 2013 |
| Tracking patients by a coordinating center enhances patient retention in multi-center community-based trials JM Holmes, HA Gillespie, NM Boyle, A Lawson, RW Beck, MX Repka CONTROLLED CLINICAL TRIALS 24, 117S-118S, 2003 | | 2003 |
Michael Boeckh, MDProfessor, Vaccine and Infectious Disease Division, Fred Hutchinson Cancer CenterVerified email at fredhutch.org
